参考文献/References:
[1] Gao Zhenzhen,Chen Wei,Zhang Xiaohua,et al.Icotinib,a potent and specific EGFR tyrosine kinase inhibitor,inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling [J].Biomed Pharmacother,2013,67(5):351-356.
[2] Camidge D R.Icotinib:kick-starting the Chinese anticancer drug industry [J].Lancet Oncol,2013,14(10):913-914.
[3] Shi Yuankai,Zhang Li,Liu Xiaoging,et al.Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer(ICOGEN):a randomised,double-blind phase 3 non-inferiority trial [J].Lancet Oncol,2013,14(10):953-961.
[4] 杨彩玲,韩新光.盐酸埃克替尼对人舌鳞状细胞癌Tca8113细胞增殖的影响 [J].郑州大学学报:医学版,2008,43(4):701-703.
[5] 杨彩玲,韩新光,于春亚.盐酸埃可替尼对人舌鳞状细胞癌Tca8113细胞周期及CyclinD1、P27表达的影响 [J].郑州大学学报:医学版,2011,46(1):82-85.
[6] Taniwaki K,Fukamachi H,Komori K,et al.Stroma-derived matrix metalloproteinase(MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice [J].Cancer Res,2007,67(9):4311-4319.
[7] 卢友光,周鸿鹰,丁林灿,等.涎腺腺样囊性癌高、低转移细胞系基因表达谱及基质金属蛋白酶表达差异 [J].中华医学遗传学杂志,2006,23(5):505-510.
[8] Eimoneim H M,Zaghloul N M.Expression of E-cadherin,N-cadherin and snail and their correlation with clinicopathological variants:an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt [J].Clinics(Sao Plaulo),2011,66(10):1765-1771.
[9] Hashimoto T,Soeno Y,Maeda G,et al.Progression of oral squamous cell carcinoma accompanied with reduced e-cadherin expression but not cadherin switch [J].Plos One,2012,7(10):e47899.
[10] Wells A,Yates C,Shepard C R,et al.E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas [J].Clin Exp Metastasis,2008,25(6):621-628.
[11] Yauch R L,Januaro T,Eberhard D A,et al.Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients [J].Clin Cancer Res,2005,11(24):8686-8698.
[12] Witta S E,Gemmill R M,Hirsch F R,et al.Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines [J].Cancer Res,2006,66(2):944-950.